K-Drops

Ketotifen hydrogen fumarate, the active ingredient in K-Drops, is an antihistamine (H1 receptor antagonist) and mast cell stabilizer presented as eye drops for ocular use. It alleviates allergic conjunctivitis, seasonal allergic eye disease, and ocular itching and redness caused by allergy.

GNH USA supplies K-Drops as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches for global distribution. These products meet EU pharmacopeial specifications and are available in bulk or retail packaging.

K-Drops (ketotifen hydrogen fumarate) is used to manage allergic eye conditions by inhibiting histamine‑mediated responses.

Allergic conjunctivitis: Reduces inflammation, itching and redness in the conjunctiva. Seasonal allergic eye disease: Controls seasonal flare‑ups of ocular allergy symptoms. Ocular itching and redness due to allergy: Provides rapid relief of itching, burning and hyperemia.

K-Drops is generally well tolerated, but ocular preparations can cause local reactions.

Common Side Effects: - Transient burning or stinging sensation after instillation. - Mild eye irritation or foreign‑body feeling. - Temporary blurred vision. - Increased tear production. - Conjunctival hyperemia (redness). - Mild eyelid swelling.

Serious or Rare Side Effects: - Severe allergic reaction (e.g., angio‑edema of the eyelid). - Corneal ulcer or epithelial defect. - Persistent eye pain or photophobia. - Significant visual acuity changes. - Secondary ocular infection. - Anaphylaxis (extremely rare).

Before using K-Drops, consider the following safety measures.

Pregnancy: Safety not established; use only if clearly needed. Breastfeeding: Unknown excretion; weigh benefits against potential risks. Contact lens wearers: Remove lenses before instillation and wait several minutes before reinserting. Concurrent ocular infection: Do not use until infection is resolved. Hypersensitivity: Avoid if known allergy to ketotifen or any excipient. Store at room temperature: Keep in the original container, protect from light and moisture.

K-Drops may interact with other ophthalmic or systemic agents.

Major Interactions (Avoid): - Use with other mast cell stabilisers may increase ocular irritation. - Concurrent topical vasoconstrictors can exacerbate local dryness.

Moderate Interactions (Monitor Closely): - Systemic antihistamines may potentiate local antihistaminic effect, leading to increased dryness. - Co‑administration with topical corticosteroids may mask signs of infection. - Use with preservative‑containing eye drops may increase risk of corneal toxicity. - Combination with ocular anesthetics may prolong numbness. - Concurrent use of glaucoma medications should be monitored for intra‑ocular pressure changes.